Literature DB >> 19473196

CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.

Hong-Yan Ling1, He-Sheng Ou, Shui-Dong Feng, Xiao-Ying Zhang, Qin-Hui Tuo, Lin-Xi Chen, Bing-Yang Zhu, Zhi-Ping Gao, Cao-Ke Tang, Wei-Dong Yin, Liang Zhang, Duan-Fang Liao.   

Abstract

1. MicroRNAs (miRNAs) play essential roles in many biological processes. It is known that aberrant miRNA expression contributes to some pathological conditions. However, it is not known whether miRNAs play any role in the development of insulin resistance in adipocytes, a key pathophysiological link between obesity and diabetes. 2. To investigate the function of miRNAs in the development of insulin resistance, using miRNA microarray analysis we compared miRNA expression profiles between normal insulinsensitive 3T3-L1 adipocytes and 3T3-L1 adipocytes rendered insulin resistant following treatment with high glucose (25mmol/L) and high insulin (1 mol/L). Furthermore, adipocytes were transfected with specific antisense oligonucleotides against miRNA-320 (anti-miR-320 oligo) and the effects on the development of insulin resistance were evaluated. 3. We identified 50 upregulated and 29 downregulated miRNAs in insulin-resistant (IR) adipocytes, including a 50-fold increase in miRNA-320 (miR-320) expression. Using bioinformatic techniques, the p85 subunit of phosphatidylinositol 3-kinase (PI3-K) was found to be a potential target of miR-320. In experiments with anti-miR-320 oligo, insulin sensitivity was increased in IR adipocytes, as evidenced by increases in p85 expression, phosphorylation of Akt and the protein expression of the glucose transporter GLUT-4, as well as insulin-stimulated glucose uptake. These beneficial effects of anti-miR-320 oligo were observed only in IR adipocytes and not in normal adipocytes. 4. In conclusion, the miRNA profile changes in IR adipocytes compared with normal 3T3-L1 adipocytes. Anti-miR-320 oligo was found to regulate insulin resistance in adipocytes by improving insulin–PI3-K signalling pathways. The findings provide information regarding a potentially new therapeutic strategy to control insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473196     DOI: 10.1111/j.1440-1681.2009.05207.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  76 in total

1.  Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems.

Authors:  Huibin Tang; Myung Lee; Orr Sharpe; Louis Salamone; Emily J Noonan; Chuong D Hoang; Sanford Levine; William H Robinson; Joseph B Shrager
Journal:  FASEB J       Date:  2012-07-05       Impact factor: 5.191

2.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

Review 3.  Genetics and Epigenetics of Infertility and Treatments on Outcomes.

Authors:  Margareta D Pisarska; Jessica L Chan; Kate Lawrenson; Tania L Gonzalez; Erica T Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 4.  Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.

Authors:  Naoko Hashimoto; Tomoaki Tanaka
Journal:  J Hum Genet       Date:  2016-12-08       Impact factor: 3.172

5.  Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity.

Authors:  B Zhou; C Li; W Qi; Y Zhang; F Zhang; J X Wu; Y N Hu; D M Wu; Y Liu; T T Yan; Q Jing; M F Liu; Q W Zhai
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

6.  The levels of human milk microRNAs and their association with maternal weight characteristics.

Authors:  Y Xi; X Jiang; R Li; M Chen; W Song; X Li
Journal:  Eur J Clin Nutr       Date:  2015-10-21       Impact factor: 4.016

Review 7.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.

Authors:  Ravi Kasiappan; Dheeran Rajarajan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

8.  AKT-ing via microRNA.

Authors:  Danish Sayed; Maha Abdellatif
Journal:  Cell Cycle       Date:  2010-08-10       Impact factor: 4.534

9.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

Review 10.  Role of miRNAs in the pathogenesis of T2DM, insulin secretion, insulin resistance, and β cell dysfunction: the story so far.

Authors:  Prabhsimran Kaur; Sushil Kotru; Sandeep Singh; Bidwan Sekhar Behera; Anjana Munshi
Journal:  J Physiol Biochem       Date:  2020-08-04       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.